Population pharmacokinetics of survodutide in subjects with overweight or obesity with and without Type 2 Diabetes Mellitus based on Phase I and Phase II data

PAGE 32 (2024) Abstr 11127
Smania G, Glatard A, Bergstrand M, Schmid B, Retlich S, Wojtyniak JG.
ConferenceEndocrinologyMetabolismObesityPharmacometrics

Pharmetheus Affiliates

Portrait-of-Giovanni-Smania-Pharmetheus
Principal Director, MIDD Consultant

Giovanni Smania

See bio
Portrait-of-Anais-Glatard_Pharmetheus
Senior Director, MIDD Consultant

Anaïs Glatard

See bio
Portrait-of-Martin-Bergstrand_Pharmetheus
Principal Director, MIDD Scientific Lead

Martin Bergstrand

See bio